By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today said that it has received CLIA certification for its laboratory in Irvine, Calif.

The Liege, Belgium-based firm also said that the lab has passed inspection by the California Department of Health and is now fully licensed and operational.

MDxHealth plans to offer epigenetic diagnostic products for a number of cancer indications. Its first assay, Prostate ConfirmMDx will be launched in the first half of this year, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.